Project Details
Description
Direct protein phosphatase 2A (PP2A) activators as novel Alzheimer's Disease (AD) therapeutics
| Status | Active |
|---|---|
| Effective start/end date | 3/1/24 → 2/28/25 |
Funding
- ATUX ISKAY GROUP LLC
- NATIONAL INSTITUTES OF HEALTH (NIH)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.